Interlocking fingers test: Administration, scoring and interpretation

The interlocking fingers test is a rapid bedside screen for parietal lobe dysfunction. The examiner demonstrates four interlocking finger figures, and the patient copies each one in turn. Every figure copied correctly scores one point, so the total runs from 0 to 4. A score of 2 or below points to constructional apraxia and warrants a full cognitive assessment.

The test was first described by Moo et al. in the Journal of Neurology, Neurosurgery and Psychiatry in 2003. It takes under two minutes and needs no form, no pen, and no training beyond the four figures. Neurology, geriatrics, and primary care teams use it to decide who needs a longer battery.

Four versions have been published since. Only the largest of them, ILFT 15, carries cut-offs validated in a patient population.

Found our content helpful?

Key takeaways

The interlocking fingers test screens for parietal lobe dysfunction using four imitated finger figures, scored out of 4. It does not diagnose dementia on its own.

Failure to reproduce the figures is associated with constructional apraxia, which turns up in Alzheimer’s disease, stroke, and Parkinson’s disease with cognitive involvement.

A 2022 study tested four variants of the original. ILFT 15 uses five figures and a three-point scale, and it performed best in Parkinson’s disease.

Reported sensitivity runs from about 39% to 79%, depending on the cut-off used, so a pass never rules out early disease.

The test complements the MoCA or MMSE rather than replacing them. A positive result should always trigger a full cognitive assessment.

What is the interlocking fingers test and why is it used?

The interlocking fingers test is a bedside cognitive screen built on imitation. The examiner demonstrates four interlocking finger figures, and the patient copies each one without physical help.

Its clinical value rests on the parietal lobe’s role in visuospatial processing and constructional praxis. Damage to that region leaves patients unable to copy spatial arrangements, even when vision and motor strength are intact.

The original paper positioned the test as a rapid flag for parietal lobe lesions during a hospital neurological examination. It needs no printed materials, no scoring sheet, and no training beyond familiarity with the four figures. It has since spread to geriatric wards, memory services, and primary care rooms where a full battery is impractical.

Memory services rarely sit on their own. Where cognitive screening runs alongside talking therapies and psychiatric review, unified therapy practice management keeps the score and the clinical notes in one record. The next clinician reads the result without hunting for a loose sheet.

What the test measures

The interlocking fingers test evaluates three cognitive-motor domains at once. Each one contributes to whether a patient can imitate the examiner’s hand posture.

• Comprehension: The patient has to understand the instruction to watch and copy. Receptive language problems or severe inattention produce failure regardless of parietal function.
• Motor coordination: Fine motor control of both hands is required. Arthritis, contracture, or upper limb weakness can produce a false positive, so note any of it.
• Short-term memory recall: The patient has to hold the demonstrated posture in working memory long enough to reproduce it. Rapid forgetting of the model is itself a meaningful finding.

Beyond those three domains, the test targets constructional apraxia, a difficulty assembling parts into a whole despite intact limb power. Constructional apraxia is a hallmark of parietal impairment, and it turns up often in memory care caseloads. Teams that log the finding in a mental health EMR can compare today’s score against the last one.

How to administer the interlocking fingers test step by step

Administering the test correctly means following the same protocol every time. The set contains four figures, and variation in how they are demonstrated is a known source of inter-rater unreliability.

The four figures were published as drawings alongside the original paper. The descriptions below are a working translation of that figure set rather than a replacement for it. Keep a printed copy of the figures in the room, so every examiner demonstrates the same four configurations.

1. Position the patient: Seat the patient facing you at eye level. Both hands should be visible and resting on a flat surface or the lap. Confirm they can see your hands clearly.
2. Instruct the patient: Say, “I am going to make a shape with my hands. Watch carefully and then copy exactly what I do.” Do not let the patient touch your hands.
3. Demonstrate figure 1: Hold both hands in front of you at chest height. Interlace the fingers of both hands fully, palms facing each other. Hold it steady for about three seconds, then ask the patient to copy it.
4. Demonstrate figure 2: Interlace the fingers again, then rotate both hands so the palms face away from you. The patient now has to work out the rotation as well as the interlock.
5. Demonstrate figure 3: Use a partial interlock. Pass only the index and middle fingers of each hand between the index and middle fingers of the other hand. Keep the remaining fingers folded down.
6. Demonstrate figure 4: Hold one hand palm down with the fingers spread. Bring the other hand up from underneath and thread its fingers through, so the two hands meet at roughly right angles. This is the most spatially complex figure, and the one patients with parietal dysfunction fail most often.
7. Score each figure: Award one point for every figure whose interlocking finger component is copied correctly. The non-interlocking fingers and the posture of the arms are not scored. Totals run from 0 to 4.
8. Record the errors, not just the total: Note whether each figure was right first time, after a second demonstration, or not at all. Record the error type as well: mirror reversal, incorrect finger placement, or spatial rotation.

One practical point. If a patient has problems in both hands, document that before you administer. A failed test alongside significant hand pathology cannot be read as evidence of parietal dysfunction.

Clinicians who record these details in structured patient record systems can tie the examination findings to the assessment outcome for cleaner tracking over time.

The modified versions: ILFT 4, 5, 12, and 15

A 2022 study in Brain and Behavior tested four variants of the original against each other. Two of them change the number of figures, and two change the scoring. They are labeled ILFT 4, ILFT 5, ILFT 12, and ILFT 15.

ILFT 4 is the original: four figures, one point each, maximum score 4. ILFT 5 adds a fifth figure on the same one-point scale. ILFT 12 keeps the four original figures but scores each one out of three.

In that three-point scheme, each figure earns up to three points:

• One point for the interlocking finger component.
• One point for the non-interlocking fingers.
• One point for how the two hands sit relative to each other.

ILFT 15 combines both changes, using five figures on the three-point scale.

The four versions differ on two axes only, and the table below sets them side by side.

ILFT 15 performed best in the study’s Parkinson’s disease cohort. Its cut-off was 12.5 for visuospatial deficits and 10.5 for dementia. A modified version is worth the extra minute where documentation has to be systematic, such as in research or across a multi-clinician team.

One point is worth stating plainly, because it causes regular confusion. No published version of this test uses three figures. A three-posture bedside task described as the interlocking fingers test is almost always a mix-up with Luria’s fist-edge-palm sequence. That one assesses motor sequencing rather than constructional praxis.

How to score the four figures

The original version awards one point for each of the four figures the patient imitates correctly, giving a total between 0 and 4. Only the interlocking finger component counts, so the non-interlocking fingers and the posture of the arms are ignored. The modified variants score each figure out of three instead.

In the original four-figure version, a total of 2 or less out of 4 is treated as clinically significant. The modified versions use cut-offs that vary by population, such as 10.5 out of 15 for dementia in Parkinson’s disease.

Apply the threshold validated for your patient group. Recording the error type, not just the total, gives you far more to work with when you plan follow-up.

Interpreting the results

Interpreting a result means pairing the score with the patient’s broader clinical picture. A failed result is a signal to investigate further, not a diagnosis. The Oxford Academic review of IFT clinical utility reports sensitivity of roughly 39% to 79%, depending on the cut-off and the population. It reaches 79% at a cut-off below 4 out of 4, and falls to 39-42% at a stricter cut-off below 3 out of 4.

The table below maps result patterns to likely clinical correlates, based on published research.

The conditions most often associated with failure are Alzheimer’s disease and other dementias, stroke involving the parietal cortex, and Parkinson’s disease with cognitive involvement. In each case the result argues for further assessment rather than confirming a specific diagnosis.

Using the test in Parkinson’s disease

The interlocking fingers test has specific research validation in Parkinson’s disease, which makes it a useful addition to routine PD cognitive monitoring. PD affects motor control and visuospatial processing through dopaminergic disruption in the basal ganglia. Parietal cortex involvement adds to that as the disease progresses.

Two practical considerations apply when you administer it to PD patients. First, tremor and rigidity affect fine motor execution independently of cognition. A patient with advanced motor PD may fail because of motor impairment rather than parietal dysfunction, so note the mechanism of failure explicitly.

Second, the 2022 modification was validated in a Parkinson’s disease cohort. ILFT 15 is therefore the version to reach for when PD is the primary clinical concern. Rehabilitation teams often fold it into regular review cycles, using a standardized template to track change across visits rather than reading one score in isolation.

How the test compares to MoCA and MMSE

The interlocking fingers test does not replace the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). It covers a narrower domain, much faster. Knowing where the differences sit helps you choose between a first-pass triage and a full battery.

Serial cognitive assessment works best when every tool has a template in the same system. Practice management software like Pabau can hold an IFT, MoCA, or MMSE form inside the patient record. Results then sit next to appointment history and clinical notes. If you want the MMSE on paper first, our MMSE screening template is free to download.

Limitations worth knowing before you rely on it

No bedside screen is free of constraints. Know where this one stops before you use it as a triage tool.

• Not a standalone diagnostic: A failed test indicates the need for further assessment. It cannot confirm dementia, locate a lesion, or replace neuroimaging.
• Hand disabilities produce false positives: Arthritis, contracture, peripheral neuropathy, and upper limb weakness all impair posture reproduction without any parietal involvement. Document hand status before you interpret the score.
• Cultural and educational variability: Understanding the instruction depends on language ability and baseline education. A patient who misses the instruction fails for reasons unrelated to cognition.
• Examiner inconsistency: Demonstration variability is the main source of inter-rater unreliability. Working from the printed figure sheet and the modified scoring protocol reduces it substantially.
• Sensitivity ceiling: Sensitivity runs from about 39% to 79%, depending on the cut-off. At the stricter cut-off the test misses most patients with parietal dysfunction, so a pass does not rule out early disease.
• Limited domain coverage: The test does not assess memory registration, language, executive function, or orientation. A patient with frontal lobe or hippocampal pathology can pass it and still score badly on a full battery.

The American Academy of Neurology recommends reading any cognitive screening result alongside clinical history, collateral information from caregivers, and functional assessment. The interlocking fingers test fits that framework as an efficient first filter rather than a conclusive evaluation.

How Pabau supports cognitive screening documentation

The interlocking fingers test produces a data point that has to land somewhere useful. In many practices it lands on a handwritten note that never reaches the patient’s longitudinal record. Repeat assessments then lose their comparative value, and the follow-up never gets booked.

Pabau handles that in four ways relevant to teams running regular cognitive screens:

• Standardized assessment templates: Build a structured IFT template inside the consultation notes module. Give it a field for each figure, the error type, the score out of 4, and your interpretation. Every clinician works from the same template, which cuts documentation variation across the team. Pabau Scribe, our AI scribe, can draft the note during or straight after the consultation.
• Integrated patient timeline: Results sit alongside appointment history, referral letters, and earlier assessment scores in one record. A clinician reviewing the patient three months later can compare today’s performance against the baseline without opening a second document.
• Automated follow-up scheduling: Automated workflows can raise a follow-up booking or a referral task whenever a cognitive screen is recorded as abnormal. Identification and action stay connected, so no failed screen sits unactioned.
• Multi-clinician access: In a multi-practitioner neurology or geriatrics team, a shared template means whoever sees the patient records and interprets the result the same way. Nobody has to decode a colleague’s note-taking habits.

For practices running serial cognitive monitoring, structured digital forms and one integrated record cut the admin work of tracking outcomes over time. Pabau is rated 4.7/5 on Capterra from 600+ verified reviews, with clinical documentation and multi-practitioner functionality cited most often.

Keep every cognitive screen in the patient record

Pabau lets neurology and geriatrics teams record structured assessment results directly in the patient record. Follow-up assessments get scheduled automatically, and standardized screening templates keep every clinician consistent.

Book a demo

Conclusion

The interlocking fingers test earns its place at the bedside. It returns something usable in under two minutes, with nothing in your hands but your hands. It will not replace the MoCA or the MMSE, and it cannot stand alone as a diagnosis. Use it to decide who needs the longer assessment, and record the error type alongside the score.

The trade-off worth remembering is the sensitivity floor. At a strict cut-off the test misses a large share of parietal dysfunction, so a clean 4 out of 4 settles nothing on its own. Pair it with the clinical history and a collateral account before you reassure anyone.

A second test is only worth doing if the first one is still findable. Keeping the score, the error type, and the follow-up in one record is what makes that true. Book a demo to see how Pabau keeps screening results and follow-up tasks on the same patient timeline.

Continue your research

Building out the wider bedside examination? Mental state examination covers the structured observation that sits around a screen like this one, domain by domain.

Explaining a dementia trajectory to a family? 7 stages of dementia chart lays out the progression in a format you can hand to a caregiver during the consultation.

Looking for follow-up activities after a positive screen? Dementia worksheets template provides structured cognitive exercises you can use between review appointments.

Frequently asked questions